LifeStance Health Group, Inc.

NasdaqGS LFST

LifeStance Health Group, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD 14.11 M

LifeStance Health Group, Inc. EBITDA is USD 14.11 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 111.38% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

LifeStance Health Group, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -124.02 M, a 41.94% change year over year.
LifeStance Health Group, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -213.62 M, a -75.87% change year over year.
LifeStance Health Group, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -121.46 M.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NasdaqGS: LFST

LifeStance Health Group, Inc.

CEO	Mr. Kenneth Alan Burdick
IPO Date	June 10, 2021
Location	United States
Headquarters	4800 N. Scottsdale Road
Employees	7,269
Sector	Health Care
Industries Mental Health Telehealth

Description

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.

Key trends

Past 5 years